Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

54.16

+0.66 (1.23%)

as of Jun 5, 2026, 3:33:54 pm Market Open.

1636 watching

Investor Insights

Jun 5, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) is viewed positively by several analysts, who note its solid growth in Asia and the wealth management sector. The company is seen as a stable and reliable option, with a decent dividend yield that appeals to income-focused investors. Analysts acknowledge that while MFC has experienced some recent challenges, especially in its U.S. operations and corrections after strong performances, it maintains a healthy growth outlook. Concerns about the overall market and macroeconomic factors have led to suggestions of caution, but many believe MFC's valuation is still attractive relative to its peers, particularly the banks. In the long term, it remains a compelling investment opportunity with the potential for growth, other factors such as credit risk being minimal.

Consensus

Positive

Valuation

Fair Value

Similar

SLF

BUY

He owns Sun Life and Great West Life instead. Insurers have suffered. Growthier companies are getting the attention, especially in a low interest rate environment. Good value over time, but that's not in favour right now. Has recovered from the March lows. Nothing against it.

BUY

Allan Tong’s Discover Picks The MFC trailing PE remains a low 9.6x while the forward PE is 6x. The price-to-book has stayed at 0.75x during this pandemic. The dividend yield is nearly 6% and is safe, based on a 54% payout ratio. Quarterly revenue growth YOY is 24.2%, though quarterly earnings have sunk nearly 50%. Read 3 Forgotten Undervalued Stocks: ZBRA Stock, MFC Stock and BBBY Stock for our full analysis.

TOP PICK

To allocate hard-earned money to live on, rather than chasing FANGs. Trading at 6.3x. Decent 10% growth rate. Not much downside. Nice dividend. A no-brainer at these levels. Yield is 5.74%. (Analysts’ price target is $23.37)

HOLD

The financial complex has been hit with low interest rates that has made it harder to make money on the lending spread. The liabilities are also valued at future claims so when interest rates go down, it is a headwind. The company is doing all the right things by reducing exposure to markets and their Asian operations are doing well.

BUY

The valuation is low with low price to book. The dividend is quite good. There is just negative sentiment around lifecos in general. The market has just not responded to what they are doing. Interest rates are likely to be low for a long time which is punitive to them.

PAST TOP PICK

(A Top Pick Jul 12/19, Down 10%) Good earnings, but hurt by the perception and reality of low interest rates. Trading less than 10x earnings. A bit contrarian, but still a good entry point around $20.

HOLD

Undervalued, solid yield, reasonable payout ratio. Caught up in the value trade. Scores in top 2% of valuation. Will do better when yields start to rise. Will catch a bid with inflation. Don't give up on it.

PAST TOP PICK

(A Top Pick Jul 11/19, Down 16%) All the financial companies, including insurance and the banks, have been hammered. Low interest rates makes it difficult for these companies to make profit. When confronted with issues like these, the company has done a fine job to develop new sources of earnings. Their earnings are as high or higher than last year, when he recommended the stock. The stock is tremendously cheap at this level.

TOP PICK

When prices get down to silly valuations you just have to buy. It is very, very cheap. It has been this cheap three times in the past 10 years, but the earnings just keep rising. Yield 5.86% (Analysts’ price target is $22.32)

BUY

An uneven ride. New CEO had done a good job focusing on higher growth areas and which legacy business to get rid of. All lifecos faced writedowns because of Covid. Trades at a low price to book value, and a discount to its peers. Favours its positioning in Asia, a higher growth area and a good growth opportunity. (Analysts’ price target is $22.00)

COMMENT

Based on fundamentals, why is this so low? Very low interest rates are a reason. Insurance companies are great when rates rise. MFC is well-managed and have turned around the company in the past company, and their Asian operations are a definite plus. MFC should return to $25-30 when rates and the wider economy recover.

PAST TOP PICK

(A Top Pick Jul 11/19, Down 19%) MFC is hurt by very low interest rates; all financial stocks are. Short term this will hurt earnings, but long term he likes their huge AUM across Canada, America and Asia. Their Asian operations will see rising demand from the Asian middle class needing insurance. Since the recession, they sold a lot of operations that were interest-rate sensitive, and lingering investor fears about this are unwarranted.

BUY

They made a strong effort at communicating with the investment community. Their first quarter was fairly good. They have a strong capital base. The dividend is not in jeopardy.

HOLD

Frustrating stock! Fundamentally, the company's new CEO has been right-sizing operations and with the virus this year premiums collected have had a hard time finding yield. This has hurt the stock in the first quarter. The price to book is 0.6 times -- very attractive. She thinks this is a good hold and you have to think longer term. She does own this.

WAIT

GWO vs MFC vs SLF? In general, he thinks all insurance companies are safe here. They don't have the threat of rising loan losses, like the banks do. They trade cheaper than the banks. Capital ratios are solid. They are finding ways to deal with low interest rates. GWO has a good job. MFC is very cheap, compared to its peers. SLF has been the steady eddy of the group. He likes them all. He would buy now, but you might be able to purchase them cheaper in the next couple of months.

Showing 286 to 300 of 2,279 entries

Most Recent Experts

Brian Madden

First Avenue Investment Counsel

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Darren Sissons

Campbell Lee & Ross

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Joe Terranova

Virtus Investment Partners

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)